BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tian R, Ke C, Rao L, Lau J, Chen X. Multimodal stratified imaging of nanovaccines in lymph nodes for improving cancer immunotherapy. Adv Drug Deliv Rev 2020;161-162:145-60. [PMID: 32827558 DOI: 10.1016/j.addr.2020.08.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Cheng Z, Ma J, Yin L, Yu L, Yuan Z, Zhang B, Tian J, Du Y. Non-invasive molecular imaging for precision diagnosis of metastatic lymph nodes: opportunities from preclinical to clinical applications. Eur J Nucl Med Mol Imaging 2023;50:1111-33. [PMID: 36443568 DOI: 10.1007/s00259-022-06056-5] [Reference Citation Analysis]
2 Li H, Luo Q, Zhang H, Ma X, Gu Z, Gong Q, Luo K. Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation. Chem Soc Rev 2023;52:47-96. [PMID: 36427082 DOI: 10.1039/d2cs00437b] [Reference Citation Analysis]
3 Bhatia SN, Chen X, Dobrovolskaia MA, Lammers T. Cancer nanomedicine. Nat Rev Cancer 2022;22:550-6. [PMID: 35941223 DOI: 10.1038/s41568-022-00496-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 24.0] [Reference Citation Analysis]
4 Younis MH, Tang Z, Cai W. Multimodality imaging of nanoparticle‐based vaccines: Shedding light on immunology. WIREs Nanomed Nanobiotechnol 2022;14. [DOI: 10.1002/wnan.1807] [Reference Citation Analysis]
5 Zhou T, Xie S, Zhou C, Chen Y, Li H, Liu P, Jiang R, Hang L, Jiang G. All-In-One Second Near-Infrared Light-Responsive Drug Delivery System for Synergistic Chemo-Photothermal Therapy. ACS Appl Bio Mater 2022. [PMID: 35815771 DOI: 10.1021/acsabm.2c00208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhang T, Guo S, Li F, Lan X, Jia Y, Zhang J, Huang Y, Liang XJ. Image-guided/improved diseases management: From immune-strategies and beyond. Adv Drug Deliv Rev 2022;188:114446. [PMID: 35820600 DOI: 10.1016/j.addr.2022.114446] [Reference Citation Analysis]
7 Su T, Cheng F, Qi J, Zhang Y, Zhou S, Mei L, Fu S, Zhang F, Lin S, Zhu G. Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy. Adv Sci (Weinh) 2022;:e2201895. [PMID: 35712773 DOI: 10.1002/advs.202201895] [Reference Citation Analysis]
8 Qi S, Wang X, Chang K, Shen W, Yu G, Du J. The bright future of nanotechnology in lymphatic system imaging and imaging-guided surgery. J Nanobiotechnology 2022;20:24. [PMID: 34991595 DOI: 10.1186/s12951-021-01232-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Nakamura T, Thomas SN. Drugging the lymphatic system: An emerging opportunity for cancer immunotherapy. Adv Drug Deliv Rev 2022;180:114040. [PMID: 34763001 DOI: 10.1016/j.addr.2021.114040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Nehra M, Uthappa UT, Kumar V, Kumar R, Dixit C, Dilbaghi N, Mishra YK, Kumar S, Kaushik A. Nanobiotechnology-assisted therapies to manage brain cancer in personalized manner. J Control Release 2021;338:224-43. [PMID: 34418523 DOI: 10.1016/j.jconrel.2021.08.027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
11 Cheng G, Wu D, Wang S, Zhang X, Yu P, Chang J, Chen X. Stimuli-responsive size-changeable strategy for cancer theranostics. Nano Today 2021;38:101208. [DOI: 10.1016/j.nantod.2021.101208] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]